TNFRSF8 and lymphoma: Monitoring for signs of cutaneous or systemic lymphoma development during follow-up is essential, as an indolent course with complete resolution after regression of ulceration or inflammatory processes is indicative of atypical intravascular CD30+ T-cell proliferation.